Interview

Meet Ann West, leader of the PAAC

Sarina Neote
Nov. 15, 2023

Ann West is a professor of chemistry and biochemistry and the associate vice president for research and partnerships at the University of Oklahoma.

She’s also the new chair of the American Society for Biochemistry and Molecular Biology’s Public Affairs Advisory Committee.

Ann West
Ann West

ASBMB Today talked to West about her advocacy experience and reasons for getting involved as she embarks on her two-year term.

The interview has been condensed and edited for style and clarity.

What do you think is important for ASBMB members to know about the PAAC?

First, I think that we work very hard in representing the ASBMB.

We have a fantastic 18-member group, some of whom have been recently recruited. We discuss a lot of broad topics, we hear different opinions, and we often can come to a consensus statement that we think best represents the interests of the society. That’s not always an easy thing to do.

I hope that everyone on the PAAC feels like they have a forum for expressing views and for contributing to our public-facing documents, whether it’s a response to an agency call for information or interacting with various funding agencies on issues where we’re able to contribute.

I really hope that our members feel they have a voice and can express their opinions.

Why do you think it’s important for scientists to advocate?

Advocating is so much more important since COVID-19, honestly, because the amount of misinformation and disinformation that we all encountered was really concerning. I think that we owe it to society — in light of the federal funding that we receive — to do our best to communicate that science should be trusted. That’s an important aspect of being on the PAAC: trying to communicate with not just the membership but with the general public.

Did you have any experience with advocating before joining the PAAC?

I was a complete rookie. It was not something that was at the forefront of my mind. However, I am fairly service-minded and want to give back to both my profession and a great society like the ASBMB. So, no, I had no experience to lean on. But once I knew more, then I became interested.

What scared you about policy and advocacy?

I think, inherently, I have an introverted personality. And I was worried it was going to be too public-facing. But, you know, it really has not turned out to be what I feared.

I came to politics, in general, I would say late in life, in part because I didn't become a naturalized citizen until about five years ago. I tended to avoid political discussions or arguments. I didn’t necessarily follow a lot of what was going on in Washington, D.C. I felt like I didn't have that experience or understanding of all the things that go on in our nation's capital.

Now, of course, being a faculty member depends on federal research funding. I did want to know how our lawmakers are involved in making decisions, especially at appropriations time when budgets are being considered. And I was interested in how our federal granting agencies both received funding and allocated funding within agencies such as the National Institutes of Health and the National Science Foundation.

I became more and more and more interested, as a faculty member, because it’s part of our livelihood.

Courtesy of Ann West
Ann West and PAAC member Mary Lipton visit congressional offices during the ASBMB’s 2023 Hill Day.

How was your first in-person Capitol Hill Day in May?

I loved the experience. I loved the vibrancy of being in the Capitol Hill area and the bustling hallways of the congressional offices. Growing up in the Northeast, I’d been to Washington, D.C., a number of times but never in the halls of Congress. It was really kind of a thrill.

I was really impressed by the receptiveness of the congressional leaders we met with. I’m not sure that all of our messages were heard, but at least we were able to have a voice. And that was very rewarding.

Any final thoughts to share?

I realized, through the years, that we’re not always training the students in our laboratory to go on to do the same thing that we do. It’s been really great and refreshing to see what the younger generation is looking toward — with a science background but putting it to a different use in the area of science advocacy. If that’s what you're interested in, you should definitely pursue it.

Also, you don't have to make the decision to be an advocate at age 20. You can decide like me, a little bit older, that this is something that I can engage in and give back to a science community that nurtured my career — and hopefully be effective.

“I think that we owe it to society — in light of the federal funding that we receive — to do our best to communicate that science should be trusted.” — Ann West

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Sarina Neote

Sarina Neote is ASBMB's director of public affairs.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

ASBMB names 2025 Marion B. Sewer scholarship recipients
Society News

ASBMB names 2025 Marion B. Sewer scholarship recipients

Aug. 21, 2025

Ten undergraduates interested in biochemistry and molecular biology will each receive $2,000 toward their tuition and related educational costs.

Attie named honorary professor
Member News

Attie named honorary professor

Aug. 18, 2025

This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.

Meet the 2025 SOC grant awardees
Outreach

Meet the 2025 SOC grant awardees

Aug. 15, 2025

Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.